Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
In a surveillance study of candidemia in cancer patients that was conducted by the European Organization for Research and Treatment of Cancer, 249 episodes were noted; Candida albicans was isolated in 70% (63) of the 90 cases involving patients with solid tumors (tumor patients) and in 36% (58) of the 159 involving those with hematologic disease (hematology patients). Neutropenia in tumor patients and acute leukemia and antifungal prophylaxis in hematology patients were significantly associated with non-albicans candidemia in a multivariate analysis. Overall 30-day mortality was 39% (97 of 249). In a univariate analysis, Candida glabrata was associated with the highest mortality rate (odds ratio, 2.66). Two multivariate analyses showed that mortality was associated with older age and severity of the underlying disease. Among hematology patients, additional factors associated with mortality were allogeneic bone marrow transplantation, septic shock, and lack of antifungal prophylaxis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies also showed a significant association between receipt of antifungal prophylaxis as well as acute leukemia and a higher incidence of candidemia caused by Candida species other than C. albicans (41).”
In the citing paper
“In cancer patients, Viscoli et al. [18] also suggested that C. glabrata was associated with a higher mortality rate.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [18]
In the citing paper
“Other North American and European investigators confirmed these observations in larger hospital settings [10, 11, 13, 20, 22, 25, 26].”
From Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000 (2004) · cites this paper as [11]
In the citing paper
“Candidemia due to C. parapsilosis has increased in frequency in pediatric populations and appears to be associated with a lower mortality rate than is candidemia due to other species of Candida [110-113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
In the citing paper
“Candidemia due to C. glabrata may be associated with increased mortality in patients with cancer [113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174 · cited 1×
“However, this phenomenon has not been confirmed in large prospective studies [26-29].”
ResultSecular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758 · cited 1×
“given about the patients' predisposing conditions [15].”
Survival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679 · cited 2×
“glabrata [3, 4, 1522].”
Background
Cited by
Items 201–300 of 647
Infections by the Yeast Kodomaea ( Pichia ) ohmeri : Two Cases and Literature Review
Han, X. Y., Tarrand, J. J., & Escudero, E. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1067-3 · Cited by 60
“in cancer patients has also been seen [15, 16].”
BackgroundVelasco, E., & Bigni, R. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0546-y · Cited by 59
“glabrata, krusei, and tropicalis species in comparison with other pathogens [5, 8].”
BackgroundResultAn Introduction to the Medically Important Candida Species
Moran, G., Coleman, D., & Sullivan, D. (2014) · Candida and Candidiasis · doi:10.1128/9781555817176.ch2 · Cited by 40
Antifungal activity of Cymbopogon winterianus jowitt ex bor against Candida albicans
de Oliveira, W. A., Pereira, F. D. O., de Luna, G. C. D. G., Lima, I. O., Wanderley, P. A., de Lima, R. B., & Lima, E. D. O. (2011) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822011000200004 · Cited by 59
“In patients hospitalized with cancer, immunocompromised or who use immunosuppressive drugs colonization may progress to invasion, resulting in severe systemic disease (26, 38).”
BackgroundPrincipe, M. I. D., Sarmati, L., Cefalo, M., Fontana, C., Santis, G. D., Buccisano, F., Maurillo, L., Bellis, E. D., Postorino, M., Sconocchia, G., et al. (2016) · Mycoses · doi:10.1111/myc.12508 · Cited by 59
Candida Peritonitis: An Update on the Latest Research and Treatments
Carneiro, H. A., Mavrakis, A., & Mylonakis, E. E. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1305-2 · Cited by 59
Candidemia: species involved, virulence factors and antimycotic susceptibility.
Luca, C. D., Guglielminetti, M. L., Ferrario, A., Calabr, M., & Casari, E. (2012) · PubMed · Cited by 58
Fujihara, N., Saito, T., Kudo, T., Iinuma, Y., Ichiyama, S., & Takakura, S. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1128-2 · Cited by 58
“BSI caused by Candida parapsilosis was associated with a better prognosis, as suggested in some previous reports [34, 43].”
ResultInitial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines
Patel, M., Kunz, D. F., Trivedi, V. M., Jones, M. G., Moser, S. A., & Baddley, J. W. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.12.010 · Cited by 58
Gong, X., Luan, T., Wu, X., Li, G., Qiu, H., Kang, Y., Qin, B., Fang, Q., Cui, W., Qin, Y.-Z., et al. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.11.028 · Cited by 57
The Challenge of Invasive Fungal Infection
Pauw, B. E. D., & Meunier, F. (1999) · Chemotherapy · doi:10.1159/000048465 · Cited by 57
Self-citationInvasive candidiasis in cancer patients: observations from a randomized clinical trial
DiNubile, M. J., Hille, D. A., Sable, C. A., & Kartsonis, N. A. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.01.016 · Cited by 57
A prospective epidemiological survey of candidaemia in Sweden
Klingspor, L., Törnqvist, E., Johansson, A., Petrini, B., Forsum, U., & Hedin, G. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310017447 · Cited by 46
Nakamura, T., & Takahashi, H. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0438-y · Cited by 56
Krčméry, V., & Kovacicova, G. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00096-6 · Cited by 56
[Invasive fungal infection in immunocompromised patients].
García‐Ruiz, J. C., Amutio, E., & Pontón, J. (2004) · PubMed · Cited by 55
Girmenia, C., Nucci, M., & Martino, P. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02901.x · Cited by 55
“In a recent prospective surveillance study of fungaemia in cancer patients conducted by the Invasive Fungal Infection Cooperative Group (IFICG) of the European Organization for Research and Treatment of Cancer (EORTC) (Viscoli et al, 1999), five case of Aspergillus fungaemia (1´9% of 270 fungaemia episodes) were obser…”
BackgroundSelf-citationTrends in species causing fungaemia in a tertiary care medical centre over 12 years
Malani, P. N., Bradley, S. F., Little, R. S., & Kauffman, C. A. (2001) · Mycoses · doi:10.1046/j.1439-0507.2001.00662.x · Cited by 54
Risk factors and outcome for nosocomial breakthrough candidaemia
Pasqualotto, A. C., Nedel, W. L., Machado, T. S., & Severo, L. C. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.04.020 · Cited by 54
Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil
Bergamasco, M. D., Garnica, M., Colombo, A. L., & Nucci, M. (2012) · Mycoses · doi:10.1111/myc.12013 · Cited by 55
Candidaemia and cancer: patients are not all the same
Pasqualotto, A. C., Rosa, D. D., Medeiros, L. R., & Severo, L. C. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-50 · Cited by 54
“According to previous studies [3,12], our haematological patients with candidaemia received chemotherapy more frequently than patients with solid tumours.”
BackgroundResultBarker, K. S., Liu, T., & Rogers, P. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/432487 · Cited by 47
“of death in neutropenic patients with cancer [2].”
BackgroundJanssen, P. A., & van den Bossche, H. (1982) · PubMed · Cited by 54
T., B., W., F., H., B., N., B., K.-H., D., M., H., D., H., U., J., G., J.-N., M., K., et al. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0730-4 · Cited by 53
“An increase in the frequency of Candida krusei and Candida glabrata in some studies appeared to be related to fluconazole prophylaxis [46, 52, 53], while”
Leung, A. Y. H., Chim, C. S., Ho, P., Cheng, V. C., Yuen, K., Lie, A. K. W., Au, W. Y., Liang, R. H. S., & Kwong, Y. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1194 · Cited by 53
Candida albicans: Molecular interactions with Pseudomonas aeruginosa and Staphylococcus aureus
Lindsay, A. K., & Hogan, D. A. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.10.002 · Cited by 52
Invasive Saprochaete Infections: An Emerging Threat to Immunocompromised Patients
Zein, S. E., Hindy, J.-R., & Kanj, S. S. (2020) · Pathogens · doi:10.3390/pathogens9110922 · Cited by 51
Chen, C., Chen, Y., Tang, J., Yao, M., Huang, S., Tsai, W., Chen, Y., Shen, M., Wang, C., & Tien, H. (2003) · Annals of Hematology · doi:10.1007/s00277-002-0588-7 · Cited by 51
“The incidence of nosocomial candidemia was 6.6 per 1000 discharges at our hospital in 1993 [13] and was higher than those reported in America (3.3~4.9 per 1000 discharges) [ 14 , 15].”
ResultInfluentialFungal CNS infections in patients with hematologic malignancy
Pagano, L., Caira, M., Falcucci, P., & Fianchi, L. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.5.775 · Cited by 51
Safdar, A., Chaturvedi, V., Koll, B. S., Larone, D. H., Perlin, D. S., & Armstrong, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3268-3272.2002 · Cited by 46
“This rise in the rate of fungal infections is exacerbated by the increasing population of immunocompromised patients such as those with AIDS or cancer (1, 2, 8, 10, 21, 31, 33).”
BackgroundPu, S., Niu, S., Zhang, C., Xu, X., Qin, M., Huang, S., & Zhang, L. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.01.005 · Cited by 50
Candidoses et levuroses diverses
Develoux, M., & Bretagne, S. (2005) · EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses · doi:10.1016/j.emcmi.2005.04.001 · Cited by 50
Proteogenomic Analysis ofCandida glabratausing High Resolution Mass Spectrometry
Prasad, T. S. K., Gowda, H., Keerthikumar, S., Sekhar, N. R., Selvan, L. D. N., Kumar, P., Pinto, S. M., Muthusamy, B., Subbannayya, Y., Renuse, S., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200827k · Cited by 49
Multiple‐species candidemia in patients with cancer
Boktour, M. R., Kontoyiannis, D. P., Hanna, H. A., Hachem, R. Y., Girgawy, E., Bodey, G. P., & RAAD, I. I. (2004) · Cancer · doi:10.1002/cncr.20573 · Cited by 49
“cohorts of candidemic patients who are immunosuppressed.(10,14,16) However, because different Candida”
BackgroundUpdate on antifungal treatment of invasive Candida and Aspergillus infections
Maschmeyer, G., & Ruhnke, M. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.01003.x · Cited by 49
Howard, S. J., Livermore, J., Sharp, A., Goodwin, J., Gregson, L., Alastruey-Izquierdo, A., Perlin, D. S., Warn, P. A., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00621-11 · Cited by 48
Comparison of the Fungicidal Activities of Caspofungin and Amphotericin B against Candida glabrata
Barchiesi, F., Spreghini, E., Tomassetti, S., Arzeni, D., Giannini, D., & Scalise, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4989-4992.2005 · Cited by 43
“glabrata are characterized by a high mortality rate, and they are difficult to treat due to a reduced susceptibility of this species to azole drugs, especially to fluconazole (12, 14).”
BackgroundRecommendations for the management of candidemia in adults in Latin America
Nucci, M., Thompson-Moya, L., Guzman-Blanco, M., Tiraboschi, I. N., Cortes, J. A., Echevarría, J., Sifuentes, J., Zurita, J., Santolaya, M. E., Alvarado Matute, T., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.007 · Cited by 41
Candida species distribution in bloodstream cultures in Lyon, France, 1998–2001
Martin, D., Persat, F., Piens, M. A., & Picot, S. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1321-y · Cited by 47
Clinical Trials of Antifungal Prophylaxis among Patients Undergoing Surgery
Calandra, T., & Marchetti, O. (2004) · Clinical Infectious Diseases · doi:10.1086/421955 · Cited by 47
“This phenomenon has been reported in neutropenic patients with cancer who received fluconazole prophylaxis and has been associated with an increased mortality [28, 29].”
BackgroundA prospective study on fungal infection in children with cancer
El‐Mahallawy, H. A., Attia, I., Alieldin, N., SALEM, A. E., & Aboel-Naga, S. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-7-601 · Cited by 47
“Moreover, C. albicans was isolated in 70% of 249 candidaemia episodes in patients with solid tumours and 36% involving those with haematological disease in a surveillance study in cancer patients conducted by the European Organization for Research and Treatment of Cancer [ 11 ].”
BackgroundResultThe epidemiology of candidaemia and mould infections in Australia
the Australian Mycology Interest Group, & Slavin, M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.3 · Cited by 42
Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients
Hadley, S., Lee, W. W., Ruthazer, R., & Nasraway, S. A. (2002) · Critical Care Medicine · doi:10.1097/00003246-200208000-00023 · Cited by 46
Playford, E. G., Eggimann, P., & Calandra, T. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283177967 · Cited by 46
Impaired gut function as risk factor for invasive candidiasis in neutropenic patients
Blijlevens, N. M. A., Donnelly, J. P., & De Pauw, B. E. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03394.x · Cited by 41
“The low prevalence of invasive candidiasis is also borne out by others, with the incidence ranging from one case per year to an average of four cases per year (Viscoli et al, 1999).”
BackgroundThe predictors of outcome in immunocompetent patients with hematogenous candidasis
Safdar, A., Bannister, T. W., & Safdar, Z. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.05.003 · Cited by 38
Antifungal prophylaxis with azole derivatives
Castagnola, E., Machetti, M., Bucci, B., & Viscoli, C. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00847.x · Cited by 46
Self-citationMoore, C. B., Oakley, K. L., & Denning, D. W. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.00158.x · Cited by 46
Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital
Sabino, R., Veríssimo, C., Brandão, J. C., Alves, C., Parada, H., Rosado, L., Paixão, E., Videira, Z., Tendeiro, T. C., Sampaio, P., et al. (2009) · Medical Mycology · doi:10.3109/13693780903161216 · Cited by 45
Ellis, M., Hedstrom, U., Jumaa, P., & Bener, A. (2003) · Medical Mycology · doi:10.1080/13693780310001645337 · Cited by 42
Khan, Z., Ahmad, S., Mokaddas, E., Meis, J. F., Joseph, L., Abdullah, A., & Vayalil, S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01926-17 · Cited by 42
“The species appears to have greater propensity to cause invasive disease in neutropenic patients and may be responsible for higher mortality than Candida albicans (3, 4).”
BackgroundCandidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors
Boo, T. W., O'Reilly, B., O'Leary, J., & Cryan, B. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01134.x · Cited by 37
Abutarif, M. A., Krishna, G., & Statkevich, P. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903485056 · Cited by 43
Cornely, O. A., Aversa, F., Cook, P., Jones, B., Michallet, M., Shea, T. C., & Vallejo, C. T. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01682.x · Cited by 44
“Invasive candidiasis is associated with high mortality rates; a review of IFI-related mortality in Europe reported mortality rates from Candida fungemia ranging from 24% to 59% (11, 12).”
BackgroundProphylaxis and Empirical Therapy of Infection in Cancer Patients
Castagnola, E., Mikulska, M., & Viscoli, C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00310-6 · Cited by 43
Self-citationBarchiesi, F., Spreghini, E., Maracci, M., Fothergill, A. W., Baldassarri, I., Rinaldi, M. G., & Scalise, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3317-3322.2004 · Cited by 43
“glabrata are characterized by a high mortality rate (37); and third, C.”
BackgroundPredictors of outcome in cancer patients with candidemia
Uzun, Ö., & Anaissie, E. J. (2000) · Annals of Oncology · doi:10.1023/a:1008308923252 · Cited by 43
“Two additional studies evaluated the prognostic factors of candidemia in cancer patients with multivariate analysis (with 5% confidence intervals) (Table 2) [13, 15].”
BackgroundMencacci, A., Cenci, E., Bacci, A., Bistoni, F., & Romani, L. R. (2000) · The Journal of Infectious Diseases · doi:10.1086/315277 · Cited by 43
Is Candida kefyr an Emerging Pathogen in Patients with Oncohematological Diseases?
Sendid, B., Lacroix, C., & Bougnoux, M. (2006) · Clinical Infectious Diseases · doi:10.1086/506573 · Cited by 37
Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality
Bader, M. S., Lai, S. M., Kumar, V., & Hinthorn, D. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021126 · Cited by 37
“tropicalis candidemia in cancer patients (12).”
BackgroundEvidence for a Pseudo-Outbreak of Candida guilliermondii Fungemia in a University Hospital in Brazil
Medeiros, E. A. S., Lott, T. J., Colombo, A. L., Godoy, P., Coutinho, A. P., Braga, M. S., Nucci, M., & Brandt, M. E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01878-06 · Cited by 35
“guilliermondii infection are associated with oncology patients (8, 16, 19).”
BackgroundCesaro, S., Tridello, G., Blijlevens, N. M. A., Ljungman, P. T., Craddock, C., Michallet, M., Martin, A. M., Snowden, J. A., Mohty, M., Maertens, J. A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy150 · Cited by 42
Cota, J., Carden, M., Graybill, J. R., Najvar, L. K., Burgess, D. S., & Wiederhold, N. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00538-06 · Cited by 40
“Infections caused by Candida glabrata have been reported to be increasing in frequency (19, 30) and are associated with high mortality rates for the elderly, immunocompromised patients, and patients in intensive care units (2, 11, 27).”
BackgroundLiu, F., Zhong, L., Zhou, F., Zheng, C., Zhang, K., Cai, J., Zhou, H., Tang, K., Dong, Z., Cui, W., et al. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s323583 · Cited by 41
Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility
Nieto, M. C., Tellería, O., & Cisterna, R. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.05.021 · Cited by 41
“krusei IC has been reported inpatientswith cancer (Viscoli et al., 1999; Wingard et al., 1991).”
BackgroundBloodstream infections in haematology: Risks and new challenges for prevention
Worth, L. J., & Slavin, M. A. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.10.003 · Cited by 41
The changing spectrum of candidemia in oncology patients: therapeutic implications
Marr, K. A. (2000) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200012000-00006 · Cited by 41
Jahanshiri, Z., Manifar, S., Moosa, H., Asghari-Paskiabi, F., Mahmoodzadeh, H., Shams‐Ghahfarokhi, M., & Razzaghi‐Abyaneh, M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.01.001 · Cited by 41
Arega, B., Woldeamanuel, Y., Adane, K., Abubeker, A., & Asrat, D. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s168867 · Cited by 41
“albicans spp.(10,44) In the current study, none of the participants had used an antifungal agent, and this could have been the reason for the lower proportion of nonC.”
Bacteremia in Childhood Cancer
Celkan, T. T., Ozkan, A., Apak, H., Diren, Ş., Can, G., Yüksel, L., & Yıldız, İ. (2002) · Journal of Tropical Pediatrics · doi:10.1093/tropej/48.6.373 · Cited by 41
Antifungal combination treatment: a future perspective
Fohrer, C., Fornecker, L., Nivoix, Y., CORNILA, C., MARINESCU, C., & Herbrecht, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.016 · Cited by 41
“Furthermore, ortality rates remain unacceptably high: nearly 30% in invaive aspergillosis, 39% in invasive candidiasis, about 70% in usarium infections and up to 80% in zygomycosis [1–4].”
BackgroundInvasive candidiasis and candidaemia in neonates and children: update on current guidelines
Tragiannidis, A., Tsoulas, C., & Groll, A. H. (2014) · Mycoses · doi:10.1111/myc.12268 · Cited by 40
Invasive candidiasis: update on current pharmacotherapy options and future perspectives
Tragiannidis, A., Tsoulas, C., Kerl, K., & Groll, A. H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.805204 · Cited by 40
“krusei are more frequently isolated in patients with hematological malignancies compared with those with solid tumors or without neutropenia [11,21].”
BackgroundKovacicova, G., Krupova, Y., Lovaszova, M., Obertik, T., Krcmery, V., Roidova, A., Trupl, J., Liskova, A., Hanzen, J., Milosovic, P., et al. (2000) · Journal of Infection and Chemotherapy · doi:10.1007/s101560070006 · Cited by 39
Self-citationIs there a need for new antifungal agents?
de Pauw, B. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00006.x · Cited by 39
Invasive mycoses in children receiving hemopoietic SCT
Castagnola, E., Faraci, M., Moroni, C., Bandettini, R., Granata, C., Caruso, S., Bagnasco, F., Caviglia, I., Mikulska, M., Furfaro, E., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.67 · Cited by 39
Self-citationA comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia
Pasqualotto, A. C., Nedel, W. L., Machado, T., & Severo, L. C. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.12.012 · Cited by 39
Recommendations for the management of candidemia in children in Latin America
Santolaya, M. E., Telles, F. D. Q., Matute, T. A., Colombo, A. L., Zurita, J., Tiraboschi, I. N., Cortés, J. A., Thompson-Moya, L., Guzmán-Blanco, M., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.010 · Cited by 38
Novel fluconazole derivatives with promising antifungal activity
Chandrika, N. T., Shrestha, S. K., Ngo, H., Howard, K. C., & Garneau‐Tsodikova, S. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.12.018 · Cited by 38
Xiang, H., Xiong, L., Liu, X., & Tu, Z. (2007) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2007.01.011 · Cited by 38
Persistent Candidemia: Causes and Investigations
Nucci, M. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0039-1 · Cited by 37
“[ 14 ] 1999 Prospective, cancer patients (adults and children) 249 Nor reported Persistently positive blood culture >2 days 116 of 249 (47%): more frequent among patients with hematologic malignancies (73%) than solid tumors (26%) Not reported”
BackgroundRuhnke, M., & Schwartz, S. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620716656381 · Cited by 37
Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan
Morii, D., Seki, M., Binongo, J., Ban, R., Kobayashi, A., Sata, M., Hashimoto, S., Shimizu, J., Morita, S., & Tomono, K. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.05.009 · Cited by 37
“They are important in clinical settings because the mortality rate associated with candidemia is very high [2,3].”
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mikulska, M., Bassetti, M., Ratto, S., & Viscoli, C. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.007 · Cited by 37
Self-citationMikołajewska, A., Schwartz, S., & Ruhnke, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01961.x · Cited by 36
Antibacterial, spectral and thermal aspects of drug based‐Cu(II) mixed ligand complexes
Kharadi, G. J., & Patel, K. D. (2009) · Applied Organometallic Chemistry · doi:10.1002/aoc.1530 · Cited by 36
Epidemiology and outcome of Candida bloodstream infection in an intensive care unit in Hong Kong.
Yap, H., Kwok, K. M., Gomersall, C. D., Fung, S., Lam, T. C., Leung, P. N., Hui, M., & Joynt, G. M. (2009) · PubMed · Cited by 36
Pechlivanoglou, P., Le, H. H., Daenen, S. M. G. J., Snowden, J. A., & Postma, M. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt329 · Cited by 36
Loeffler, J., Hebart, H. F., Magga, S., Schmidt, D., Klingspor, L., Tollemar, J. G., Schumacher, U., & Einsele, H. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00201-7 · Cited by 36
Egerer, G., & Geist, M. J. P. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01979.x · Cited by 35
Apalata, T. R., Longo‐Mbenza, B., Sturm, A. W., Carr, W., & Moodley, P. (2014) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.133470 · Cited by 35
“Those risk factors for VVC include mainly pregnancy,[1,5,6] use of broad spectrum antibiotics,[7,8] uncontrolled diabetes mellitus,[9,10] use of contraceptives and hormone replacement therapy,[1,11,12] use of corticosteroids,[1] cancer chemotherapy,[13-15] organ transplantation,[13-15] tight‐fitting clothing,[1,13-15]…”
BackgroundFungal Infections in Patients With Neutropenia: Challenges in Prophylaxis and Treatment
Herbrecht, R., Neuville, S., Letscher‐Bru, V., Natarajan‐Amé, S., & Lortholary, O. (2000) · Drugs & Aging · doi:10.2165/00002512-200017050-00002 · Cited by 35
Magri, M. M. C., Gomes‐Gouvêa, M. S., de Freitas, V. L. T., Motta, A. L., Moretti, M. L., & Shikanai‐Yasuda, M. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02366-12 · Cited by 35
Fungal Infections in Cancer Patients
Angarone, M. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-04220-6_4 · Cited by 34
Dignani, M. C., Solomkin, J. S., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00008-6 · Cited by 34
Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004
Caggiano, G., Iatta, R., Laneve, A., Manca, F., & Montagna, M. T. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01452.x · Cited by 34
Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital
Luzzati, R., Allegranzi, B., Antozzi, L., Masala, L., Pegoraro, E., Azzini, A., & Concia, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01268.x · Cited by 33
Geotrichum capitatum Septicemia: Case Report and Review of the Literature
Trabelsi, H., Néji, S., Gargouri, L., Sellami, H., Guidara, R., Cheikhrouhou, F., Bellâaj, H., Makni, F., Elloumi, M., & Ayadi, M. A. (2015) · Mycopathologia · doi:10.1007/s11046-015-9869-2 · Cited by 33
“However, 60–80 % of patients with Geotrichum infection develop deep organ involvement, compared with only 10–20 % of patients with candidemia [13].”
Viscoli, C., & Castagnola, E. (1999) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(99)90019-x · Cited by 33
Self-citationSpondylodiscitis Caused by Candida krusei : Case Report and Susceptibility Patterns
Pemán, J., Jarque, I., Bosch, M., Cantón, E., Salavert, M., de Llanos, R., & Molina, A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1912-1914.2006 · Cited by 33
“cies than in those with solid tumors (16).”
Background
Metadata
- Authors
- Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., De Pauw, B., Meunier, F., & the Invasive Fungal Infection Group of the EORTC
- Affiliations
- University of Genoa (IT)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05
- Volume
- 28
- Issue
- 5
- Pages
- 1071-1079
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126536749
- Cited by
- 601
- References
- 29
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 22 · 2014: 27 · 2013: 31 · 2012: 25
- FWCI
- 21.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, invasive fungal infections, cancer patients, Candida albicans, non-albicans Candida, Candida glabrata, solid tumors, hematologic malignancies, acute leukemia, neutropenia, antifungal prophylaxis, allogeneic bone marrow transplantation, septic shock, 30-day mortality, risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candida albicans, Candidiasis, Child, Child, Preschool, Cross Infection, Female, Humans, Male, Middle Aged, Neoplasms, Neutropenia, Population Surveillance, Prospective Studies, Multivariate Analysis, Survival Analysis, Hematologic Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.